Thursday, November 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

3 Things Rich Retirees Do Differently With Their Social Security Benefits

View original at nasdaq.com
3 Things Rich Retirees Do Differently With Their Social Security Benefits Key Points Many retirees need their Social Security to cover their basic expenses…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • You get an 8% boost to your monthly Social Security checks for each year you delay claiming beyond full retirement age, up until age 70

    60% confidence
  • Contributing $500 per month to a retirement account over 42 years with an 8% annual return could result in over $1.8 million in savings

    60% confidence
  • For many retirees, Social Security benefits are a true lifeline, spelling the difference between covering essential bills or not

    60% confidence
  • Most Americans are a few years or more behind on retirement savings

    60% confidence
  • The earliest age to claim Social Security is 62

    60% confidence
  • Wealthy retirees can delay their Social Security claims until age 70 without having to wait to retire because they have enough savings to live on

    60% confidence
  • A handful of little-known Social Security secrets could help ensure a boost in retirement income, with one trick potentially paying as much as $23,760 more each year

    60% confidence
  • AI could create the world's first trillionaire through a company providing critical technology that Nvidia and Intel both need

    60% confidence
  • 8% yearly return is a bit below the stock market's average

    60% confidence
  • Millions of older Americans today collect monthly benefits from Social Security

    60% confidence
  • Full retirement age is 67 for anyone born in 1960 or later

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com